Diabetes, obesity and COVID-19: A complex interplay

Prashanth Vas, David Hopkins, Michael Feher, Francesco Rubino, Martin B. Whyte*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

52 Citations (Scopus)

Abstract

With the accumulation of observational data showing an association of metabolic co-morbidities with adverse outcomes from COVID-19, there is a need to disentangle the contributions of pre-existing macro- and microvascular disease, obesity and glycaemia. This article outlines the complex mechanistic and clinical interplay between diabetes and COVID-19, the clinical and research questions which arise from this relationship, and the types of studies needed to answer those questions. The authors are clinicians and academics working in diabetes and obesity medicine, but the article is pitched to an audience of generalists with clinical experience of or interest in the management of COVID-19.

Original languageEnglish
Pages (from-to)1892-1896
Number of pages5
JournalDiabetes, Obesity and Metabolism
Volume22
Issue number10
DOIs
Publication statusPublished - 1 Oct 2020

Fingerprint

Dive into the research topics of 'Diabetes, obesity and COVID-19: A complex interplay'. Together they form a unique fingerprint.

Cite this